Talaris Therapeutics Inc (TALS) Event June 30, 2022, 20:54 UTC 12 1 comments (10% Negative) TALARIS THERAPEUTICS, INC. (TALS) Announces Delay in reflected Development Timeline Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
MaxCyte Inc (MXCT) Event June 30, 2022, 20:44 UTC 12 1 comments (99% Neutral) MaxCyte, Inc. (MXCT) Announces Executive Changes Comment Full text
Centessa Pharmaceuticals plc (CNTA) Event June 30, 2022, 20:34 UTC 12 1 comments (99% Neutral) CENTESSA PHARMACEUTICALS PLC (CNTA) Announces Regulatory Update Comment Full text
ProQR Therapeutics (PRQR) Event June 30, 2022, 20:32 UTC 11 1 comments (99% Neutral) ProQR Therapeutics (PRQR) Announces 2022 Annual General Meeting Comment Full text
BeiGene Ltd (BGNE) Event June 30, 2022, 20:17 UTC 12 1 comments (90% Positive) BEIGENE, LTD. (BGNE) Provides Update on identified for tislelizumabCAMBRIDGE Comment Full text
Kiniksa Pharmaceuticals (KNSA) Event June 30, 2022, 20:13 UTC 13 1 comments (99% Neutral) Kiniksa Pharmaceuticals, Ltd. (KNSA) Announces Regulatory Update Comment Full text
Fate Therapeutics Inc (FATE) Event June 30, 2022, 20:06 UTC 12 1 comments (10% Negative) FATE THERAPEUTICS, INC. (FATE) Announces Delay in innovation Trials for Solid Tumors San Diego Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Curis Inc (CRIS) Event June 30, 2022, 20:05 UTC 12 1 comments (99% Neutral) CURIS INC (CRIS) Announces New Board Appointment Comment Full text
Pacific Biosciences of California Inc (PACB) Event June 30, 2022, 20:05 UTC 12 1 comments (99% Neutral) Pacific Biosciences of California, Inc. (PACB) Announces Business Combination Comment Full text
Blueprint Medicines Corp (BPMC) Event June 30, 2022, 20:05 UTC 12 1 comments (10% Negative) Blueprint Medicines Corporation (BPMC) Announces Business Combination Comment Full text